Ethical and scientific issues in studying the safety of approved drugs

Corporate Author: Institute of Medicine (U.S.) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs
Format: eBook
Language:English
Published: Washington, D.C. National Academies Press 2012, c2012
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 01562nam a2200325 u 4500
001 EB000943952
003 EBX01000000000000000737542
005 00000000000000.0
007 tu|||||||||||||||||||||
008 150223 r ||| eng
020 |a 9780309218139 
020 |a 9780309218146 
020 |a 0309218136 
245 0 0 |a Ethical and scientific issues in studying the safety of approved drugs  |h Elektronische Ressource  |c Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies 
260 |a Washington, D.C.  |b National Academies Press  |c 2012, c2012 
300 |a xvi, 275 p.  |b ill 
505 0 |a Incorporating benefit and risk assessment and benefit/risk management into food and drug administration decision-making -- Evidence and decision-making -- Selection and oversight of required postmarketing studies -- Synthesis 
505 0 |a Includes bibliographical references 
653 |a Product Surveillance, Postmarketing / methods 
653 |a United States 
653 |a Drug Evaluation / ethics 
653 |a Clinical Trials as Topic / ethics 
653 |a Drug Approval 
710 2 |a Institute of Medicine (U.S.)  |b Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
856 |u https://www.ncbi.nlm.nih.gov/books/NBK200905  |3 Volltext 
082 0 |a 658 
082 0 |a 170